Correction to: The Cost Effectiveness of Genetic Testing...

PharmacoEconomics 2020 / 3 Vol. 38; Iss. 3

Correction to: The Cost Effectiveness of Genetic Testing for CYP2C19 Variants to Guide Thienopyridine Treatment in Patients with Acute Coronary Syndromes

Panattoni, Laura, Brown, Paul M., Ao, Braden Te, Webster, Mark, Gladding, Patrick
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
38
Language:
english
Journal:
PharmacoEconomics
DOI:
10.1007/s40273-020-00885-8
Date:
March, 2020
File:
PDF, 350 KB
english, 2020
Conversion to is in progress
Conversion to is failed